This reduction in insulin with no change in plasma glucose reflects significant improvements in muscle and whole-body insulin sensitivity, as demonstrated by significant and substantial decreases in HOMAIR (homeostatic assessment of insulin resistance) and corresponding increases in skeletal muscle 18FDG uptake (Table2 and Figure4a). The gene discussed is INS; the disease is Insulin resistance.